Monica Markovski Commerford, Ph.D., holds a Doctor of Philosophy in Microbiology and Molecular Genetics from Harvard University and a certification in Human Biology and Translational Medicine from Harvard Medical School. Monica has extensive experience in regulatory affairs within the biopharmaceutical industry, currently serving as Executive Director of Regulatory Affairs CMC at Autolus Therapeutics. Previous positions include Senior Director of Global Regulatory Affairs at AlloVir, Head of Viral Vector Services Regulatory Affairs at Thermo Fisher Scientific, and Manager of Regulatory Affairs at Brammer Bio. Additionally, Monica contributes as an Advisory Council Member for Harvard Business Review.